SCHEMBL24656154

SCHEMBL24656154

Cc1ncn(-c2cccc(C(C)(C)C)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.40
OPRD1 P41143 3/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
ESRRA P11474 1/20 0.39
KIF11 P52732 1/20 0.37
HPGD P15428 1/20 0.36
CTSK P43235 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
RXRA P19793 2/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2B Q13224 2/20 0.35
CYP3A4 P08684 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20320415 0.86 NOTUM (0.55) NOTUMRXRAGRIN1GRIN2BPSEN1
SCHEMBL16202014 0.80 ALDH1A1 (0.45) RXRAGRIN1GRIN2B
SCHEMBL30186345 0.77 FGFR1 (0.44) OPRD1OPRM1OPRK1
SCHEMBL7127572 0.77 MAPT (0.49) CYP3A4PSEN1PSEN2APH1BNCSTN
SCHEMBL16202012 0.77 NOTUM (0.47) NOTUMHPGDNPC1RAB9A
SCHEMBL21863282 0.77 KEAP1 (0.47) NOTUMKEAP1RXRAGRIN1GRIN2B
SCHEMBL21863285 0.75 NOTUM (0.51) NOTUMHPGDNPC1
SCHEMBL26028864 0.75 MAPT (0.47) NOTUMOPRD1OPRM1OPRK1KEAP1
SCHEMBL16202016 0.75 MAPK8 (0.42) OPRD1OPRM1HPGDNPC1RAB9A
SCHEMBL7044640 0.75 HPGD (0.49) NOTUMHPGDNPC1RAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 931/4885OPRD1 343/4885OPRM1 449/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP NOTUM 931/4885OPRD1 343/4885OPRM1 449/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP NOTUM 931/4885OPRD1 343/4885OPRM1 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.